Cargando…

Genome editing of lactic acid bacteria: opportunities for food, feed, pharma and biotech

This mini-review provides a perspective of traditional, emerging and future applications of lactic acid bacteria (LAB) and how genome editing tools can be used to overcome current challenges in all these applications. It also describes available tools and how these can be further developed, and take...

Descripción completa

Detalles Bibliográficos
Autores principales: Börner, Rosa A, Kandasamy, Vijayalakshmi, Axelsen, Amalie M, Nielsen, Alex T, Bosma, Elleke F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322438/
https://www.ncbi.nlm.nih.gov/pubmed/30561594
http://dx.doi.org/10.1093/femsle/fny291
_version_ 1783385611306008576
author Börner, Rosa A
Kandasamy, Vijayalakshmi
Axelsen, Amalie M
Nielsen, Alex T
Bosma, Elleke F
author_facet Börner, Rosa A
Kandasamy, Vijayalakshmi
Axelsen, Amalie M
Nielsen, Alex T
Bosma, Elleke F
author_sort Börner, Rosa A
collection PubMed
description This mini-review provides a perspective of traditional, emerging and future applications of lactic acid bacteria (LAB) and how genome editing tools can be used to overcome current challenges in all these applications. It also describes available tools and how these can be further developed, and takes current legislation into account. Genome editing tools are necessary for the construction of strains for new applications and products, but can also play a crucial role in traditional ones, such as food and probiotics, as a research tool for gaining mechanistic insights and discovering new properties. Traditionally, recombinant DNA techniques for LAB have strongly focused on being food-grade, but they lack speed and the number of genetically tractable strains is still rather limited. Further tool development will enable rapid construction of multiple mutants or mutant libraries on a genomic level in a wide variety of LAB strains. We also propose an iterative Design–Build–Test–Learn workflow cycle for LAB cell factory development based on systems biology, with ‘cell factory’ expanding beyond its traditional meaning of production strains and making use of genome editing tools to advance LAB understanding, applications and strain development.
format Online
Article
Text
id pubmed-6322438
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-63224382019-01-10 Genome editing of lactic acid bacteria: opportunities for food, feed, pharma and biotech Börner, Rosa A Kandasamy, Vijayalakshmi Axelsen, Amalie M Nielsen, Alex T Bosma, Elleke F FEMS Microbiol Lett Minireview This mini-review provides a perspective of traditional, emerging and future applications of lactic acid bacteria (LAB) and how genome editing tools can be used to overcome current challenges in all these applications. It also describes available tools and how these can be further developed, and takes current legislation into account. Genome editing tools are necessary for the construction of strains for new applications and products, but can also play a crucial role in traditional ones, such as food and probiotics, as a research tool for gaining mechanistic insights and discovering new properties. Traditionally, recombinant DNA techniques for LAB have strongly focused on being food-grade, but they lack speed and the number of genetically tractable strains is still rather limited. Further tool development will enable rapid construction of multiple mutants or mutant libraries on a genomic level in a wide variety of LAB strains. We also propose an iterative Design–Build–Test–Learn workflow cycle for LAB cell factory development based on systems biology, with ‘cell factory’ expanding beyond its traditional meaning of production strains and making use of genome editing tools to advance LAB understanding, applications and strain development. Oxford University Press 2018-12-18 /pmc/articles/PMC6322438/ /pubmed/30561594 http://dx.doi.org/10.1093/femsle/fny291 Text en © FEMS 2018. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Minireview
Börner, Rosa A
Kandasamy, Vijayalakshmi
Axelsen, Amalie M
Nielsen, Alex T
Bosma, Elleke F
Genome editing of lactic acid bacteria: opportunities for food, feed, pharma and biotech
title Genome editing of lactic acid bacteria: opportunities for food, feed, pharma and biotech
title_full Genome editing of lactic acid bacteria: opportunities for food, feed, pharma and biotech
title_fullStr Genome editing of lactic acid bacteria: opportunities for food, feed, pharma and biotech
title_full_unstemmed Genome editing of lactic acid bacteria: opportunities for food, feed, pharma and biotech
title_short Genome editing of lactic acid bacteria: opportunities for food, feed, pharma and biotech
title_sort genome editing of lactic acid bacteria: opportunities for food, feed, pharma and biotech
topic Minireview
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322438/
https://www.ncbi.nlm.nih.gov/pubmed/30561594
http://dx.doi.org/10.1093/femsle/fny291
work_keys_str_mv AT bornerrosaa genomeeditingoflacticacidbacteriaopportunitiesforfoodfeedpharmaandbiotech
AT kandasamyvijayalakshmi genomeeditingoflacticacidbacteriaopportunitiesforfoodfeedpharmaandbiotech
AT axelsenamaliem genomeeditingoflacticacidbacteriaopportunitiesforfoodfeedpharmaandbiotech
AT nielsenalext genomeeditingoflacticacidbacteriaopportunitiesforfoodfeedpharmaandbiotech
AT bosmaellekef genomeeditingoflacticacidbacteriaopportunitiesforfoodfeedpharmaandbiotech